iBio, Inc. (IBIO)
1.125
+0.02
(+1.35%)
USD |
NASDAQ |
Oct 02, 16:00
1.09
-0.04
(-3.11%)
After-Hours: 20:00
iBio Shareholders Equity (Quarterly) : 85.71M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.71M |
| March 31, 2026 | 77.54M |
| December 31, 2025 | 56.56M |
| September 30, 2025 | 56.04M |
| June 30, 2025 | 14.88M |
| March 31, 2025 | 11.38M |
| December 31, 2024 | 13.90M |
| September 30, 2024 | 17.75M |
| June 30, 2024 | 21.32M |
| March 31, 2024 | 24.86M |
| December 31, 2023 | 9.197M |
| September 30, 2023 | 13.21M |
| June 30, 2023 | 15.38M |
| March 31, 2023 | 17.39M |
| December 31, 2022 | 18.82M |
| September 30, 2022 | 48.37M |
| June 30, 2022 | 63.48M |
| March 31, 2022 | 79.38M |
| December 31, 2021 | 90.60M |
| September 30, 2021 | 100.54M |
| June 30, 2021 | 108.58M |
| March 31, 2021 | 104.84M |
| December 31, 2020 | 107.34M |
| September 30, 2020 | 80.05M |
| June 30, 2020 | 56.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.966M |
| December 31, 2019 | -0.511M |
| September 30, 2019 | -1.933M |
| June 30, 2019 | 2.463M |
| March 31, 2019 | 6.907M |
| December 31, 2018 | 11.08M |
| September 30, 2018 | 13.03M |
| June 30, 2018 | 16.17M |
| March 31, 2018 | 4.154M |
| December 31, 2017 | 7.812M |
| September 30, 2017 | 6.293M |
| June 30, 2017 | 8.914M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 4.153M |
| September 30, 2016 | 7.141M |
| June 30, 2016 | 9.937M |
| March 31, 2016 | 8.265M |
| December 31, 2015 | 7.878M |
| September 30, 2015 | 9.809M |
| June 30, 2015 | 11.23M |
| March 31, 2015 | 10.19M |
| December 31, 2014 | 9.567M |
| September 30, 2014 | 5.439M |
| June 30, 2014 | 6.099M |
| March 31, 2014 | 7.001M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
| Biogen, Inc. | 18.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.11M |
| Total Liabilities (Quarterly) | 13.40M |
| Debt to Equity Ratio | 0.0256 |
| Current Ratio | 7.852 |
| Net Debt Paydown Yield | 0.34% |